Symrise partners with Aplantex for accessing plant-based molecules
Aplantex has been, since 2024, diligently involved in the research & development work to produce the initial molecule of interest requested by Symrise
Aplantex has been, since 2024, diligently involved in the research & development work to produce the initial molecule of interest requested by Symrise
CCFI clarifies that the High Court's stay applies to the ban notification
We envision 1,000+ enterprises across 50+ countries relying on Scimplify to deliver complex, high-value chemicals at scale by 2030
Facility represents the first industrial-scale application of a CO2 Electrolysis process using commercial grade and size gas diffusion electrodes measuring 1.5m2 each in surface area
The company is also planning to apply for additional 15 new generation molecules with Central Insecticide Board of India
Developing five new molecules in combination chemistries in next 4-5 years
Exciting insights into innovative resins and technologies
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
The primary objective is to provide a dynamic platform for researchers and industry experts to present their cutting-edge research findings and engage in insightful discussions
We have a strong product pipeline to be launched in coming quarters and we remain focused on strengthening our business development team
Subscribe to our newsletter & stay updated.